Endomorphin-1 and endomorphin-2 are partial agonists at the human μ- opioid receptor

European Journal of Pharmacology

Volumn 346, Issue 1, 1998, Pages 111-114

  Hosohata, Keiko ^a   Burkey, Thomas H ^a   Alfaro Lopez, Josue ^a   Varga, Eva ^a   Hruby, Victor J ^a   Roeske, William R ^a   Yamamura, Henry I ^a  

^a Biochem Psychiat Chem Prog N   (United States)

Author keywords

Opioid receptor; Efficacy; Endomorphin 1; Endomorphin 2

Indexed keywords

ENDORPHIN; ENKEPHALIN; GUANINE NUCLEOTIDE BINDING PROTEIN; MU OPIATE RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CALCULATION; CELL CLONING; CELL MEMBRANE; DRUG EFFICACY; DRUG POTENCY; FIBROBLAST; MAMMAL; NONHUMAN; PRIORITY JOURNAL; RABBIT; RECEPTOR BINDING; STATISTICAL ANALYSIS;

ANALGESICS, OPIOID; CELL LINE; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); HUMANS; OLIGOPEPTIDES; RECEPTORS, OPIOID, MU;

EID: 0032478671     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00117-4     Document Type: Article

References (19)

1. Brownstein M.J. A brief history of opiates, opioid peptides, and opioid receptors. Proc. Natl. Acad. Sci. USA. 90:1993;5391-5393.
2. Champion H.C., Zadina J.E., Kastin A.J., Hackler L., Ge L., Kadowitz P.J. The endogenous mu-opioid receptor agonists endomorphins 1 and 2 have novel hypotensive activity in the rabbit. Biochem. Biophys. Res. Commun. 235:1997;567-570.
3. 50) of an enzymatic reaction. Biochem. Pharmacol. 22:1973;3099-3108.
4. Dhawan B.N., Cesselin F., Raghubir R., Reisine T., Bradley P.B., Portoghese P.S., Hamon M. International union of pharmacology: XII. Classification of opioid receptors. Pharmacol. Rev. 48:1996;567-592.
5. Ehlert F.J. The relationship between muscarinic receptor occupancy and adenylate cyclase inhibition in the rabbit myocardium. Mol. Pharmacol. 28:1985;410-421.
6. Emmerson P.J., Clark M.J., Mansour A., Akil H., Woods J.H., Medihradsky F. Characterization of opioid agonist efficacy in a C6 glioma cell line expressing the μ opioid receptor. J. Pharmacol. Exp. Ther. 278:1996;1121-1127.
7. Furchgott R.F. The use of β-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv. Drug Res. 3:1966;21-55.
8. Hughes J., Smith T.W., Kosterlitz H.W., Fothergill L.A., Morgan B.A., Morris H.R. Identification of two related pentapeptides from the brain with potent opiate agonist activity. Nature. 258:1975;577-579.
9. Knapp R.J., Landsman R., Waite S., Malatynska E., Varga E., Haq W., Hruby V.J., Roeske W.R., Nagase H., Yamamura H.I. Properties of TAN-67, a nonpeptidic δ-opioid receptor agonist, at cloned human δ- and μ-opioid receptors. Eur. J. Pharmacol. 291:1995;129-134.
10. Lord J.A.H., Waterfield A.A., Hughes J., Kosterlitz H.W. Endogenous opioid peptides: multiple agonists and receptors. Nature. 267:1977;495-499.
11. 35S] thio)triphosphate binding Mol. Pharmacol. 44:1993;115-123.
12. Quock R.M., Hosohata Y., Knapp R.J., Burkey T.H., Hosohata K., Zhang X., Rice K., Nagase H., Hruby V.J., Porreca F., Roeske W.R., Yamamura H.I. Relative efficacies of δ-opioid receptor agonists at the cloned human δ-opioid receptor. Eur. J. Pharmacol. 326:1997;101-104.
13. + and guanyl nucleotides. J. Biol. Chem. 255:1980;820-823.
14. Ruffolo R.R.J. Important concepts of receptor theory. J. Auton. Pharmacol. 2:1982;277-295.
15. Sim L.J., Selley D.E., Xiao R., Childers S.R. Differences in G-protein activation by μ- and δ-opioid, and cannabinoid, receptors in rat striatum. Eur. J. Pharmacol. 307:1996;97-105.
16. Stone L.S., Fairbanks C.A., Laughlin T.M., Nguyen H.O., Bushy T.M., Wessendorf M.W., Wilcox G.L. Spinal analgesic actions of the new endogenous opioid peptides endomorphin-1 and -2. NeuroReport. 8:1997;3131-3135.
17. 35S] thio)triphosphate binding to membranes from human neuroblastoma SH-SY5Y cells Mol. Pharmacol. 47:1995;848-854.
18. Zadina J.E., Kastin A.J., Ge L., Hackler L. Mu, delta, and kappa opiate receptor binding of Tyr-MIF-1 and of Tyr-W-MIF-1, its active fragments, and two potent analogs. Life Sci. 55:1994;PL461-PL466.
19. Zadina J.E., Hackler L., Ge L., Kastin A.J. A potent and selective endogenous agonist for the μ-opiate receptor. Nature. 386:1997;499-501.